Spartalizumab, CAS [[1935694-88-4]]

Produktübersicht

• Artikelname: Spartalizumab, CAS [[1935694-88-4]]
• Artikelnummer: TGM-T77075
• Hersteller Artikelnummer: T77075
• Alternativnummer: TGM-T77075-1MG,TGM-T77075-5MG,TGM-T77075-10MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Spartalizumab(anti-PD-1) , PDR001

Produktbeschreibung

Spartalizumab (PDR001) is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to PD-1 at low concentrations, exhibiting high activity. It blocks the interaction with PD-L1 and PD-L2, making it suitable for studying undifferentiated thyroid cancer (ATC).

Produkteigenschaften

• Reinheit: 95.10%
• CAS Nummer: [1935694-88-4]
• Target-Kategorie: PD-1/PD-L1